Caffeine reduces hepatic lipid accumulation through regulation of lipogenesis and ER stress in zebrafish larvae

Journal of Biomedical Science

Volumn 22, Issue 1, 2015, Pages

  Zheng, Xinchun ^a   Dai, Wencong ^a   Chen, Xiaohui ^a   Wang, Kunyuan ^a   Zhang, Wenqing ^a   Liu, Li ^a   Hou, Jinlin ^a  

^a SOUTHERN MEDICAL UNIVERSITY   (China)

Author keywords

Caffeine; ER stress; Fatty liver; Lipogenesis; Zebrafish

Indexed keywords

CAFFEINE; GLUCOSE REGULATED PROTEIN 78; GROWTH ARREST AND DNA DAMAGE INDUCIBLE PROTEIN 153; INTERLEUKIN 1BETA; LIPID; TRIACYLGLYCEROL; ZEBRAFISH PROTEIN;

ACC1 GENE; ACO GENE; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; ATF6 GENE; ATG12 GENE; BECLIN 1 GENE; BIP GENE; CD36 GENE; CONTROLLED STUDY; DOWN REGULATION; DRUG EFFECT; EMBRYO; ENDOPLASMIC RETICULUM STRESS; FATTY LIVER; GENE CONTROL; GENE EXPRESSION; IL 1BETA GENE; INFLAMMATION; IRE1 GENE; LARVA; LIPID OXIDATION; LIPID STORAGE; LIPOGENESIS; NONHUMAN; OVERNUTRITION; PERK GENE; PRIORITY JOURNAL; PROTEIN EXPRESSION; SREBP1 GENE; TNF ALPHA GENE; TRIACYLGLYCEROL BLOOD LEVEL; UCP2 GENE; UPREGULATION; WEIGHT REDUCTION; ZEBRA FISH; ANIMAL; BIOSYNTHESIS; DRUG EFFECTS; GENETICS; HUMAN; LIVER; METABOLISM; NON-ALCOHOLIC FATTY LIVER DISEASE;

ANIMALS; CAFFEINE; ENDOPLASMIC RETICULUM STRESS; HUMANS; LIPIDS; LIPOGENESIS; LIVER; NON-ALCOHOLIC FATTY LIVER DISEASE; ZEBRAFISH; ZEBRAFISH PROTEINS;

EID: 84959377541     PISSN: 10217770     EISSN: 14230127     Source Type: Journal    
DOI: 10.1186/s12929-015-0206-3     Document Type: Article

References (58)

1. Della Corte C, Liccardo D, Mosca A, Vania A, Nobili V. Non-alcoholic fatty liver disease. Paediatrics and Child Health. 2013;23(12):529-34.
2. Powell EE, Cooksley WG, Hanson R, Searle J, Halliday JW, Powell LW. The natural history of nonalcoholic steatohepatitis: A follow-up study of forty-two patients for up to 21 years. Hepatology (Baltimore, Md). 1990;11(1):74-80.
3. Sanyal AJ. AGA technical review on nonalcoholic fatty liver disease. Gastroenterology. 2002;123(5):1705-25.
4. Zou Y, Li J, Lu C, Wang J, Ge J, Huang Y, et al. High-fat emulsion-induced rat model of nonalcoholic steatohepatitis. Life Sci. 2006;79(11):1100-7.
5. Baumgardner JN, Shankar K, Hennings L, Badger TM, Ronis MJ. A new model for nonalcoholic steatohepatitis in the rat utilizing total enteral nutrition to overfeed a high-polyunsaturated fat diet. Am J Physiol Gastrointest Liver Physiol. 2008;294(1):G27-38.
6. Yin HQ, Kim M, Kim JH, Kong G, Lee MO, Kang KS, et al. Hepatic gene expression profiling and lipid homeostasis in mice exposed to steatogenic drug, tetracycline. Toxicol Sci. 2006;94(1):206-16.
7. Watanabe S, Horie Y, Suzuki A. Hepatocyte-specific Pten-deficient mice as a novel model for nonalcoholic steatohepatitis and hepatocellular carcinoma. Hepatol Res. 2005;33(2):161-6.
8. Watanabe S, Horie Y, Kataoka E, Sato W, Dohmen T, Ohshima S, et al. Non-alcoholic steatohepatitis and hepatocellular carcinoma: Lessons from hepatocyte-specific phosphatase and tensin homolog (PTEN)-deficient mice. J Gastroenterol Hepatol. 2007;22 Suppl 1:S96-100.
9. Asaoka Y, Terai S, Sakaida I, Nishina H. The expanding role of fish models in understanding non-alcoholic fatty liver disease. Dis Model Mech. 2013;6(4):905-14.
10. Thakur PC, Stuckenholz C, Rivera MR, Davison JM, Yao JK, Amsterdam A, et al. Lack of de novo phosphatidylinositol synthesis leads to endoplasmic reticulum stress and hepatic steatosis in cdipt-deficient zebrafish. Hepatology (Baltimore, Md). 2011;54(2):452-62.
11. Pai WY, Hsu CC, Lai CY, Chang TZ, Tsai YL, Her GM. Cannabinoid receptor 1 promotes hepatic lipid accumulation and lipotoxicity through the induction of SREBP-1c expression in zebrafish. Transgenic Res. 2013;22(4):823-38.
12. Lu J-W, Yang W-Y, Lin Y-M, Jin S-LC, Yuh C-H. Hepatitis B virus X antigen and aflatoxin B1 synergistically cause hepatitis, steatosis and liver hyperplasia in transgenic zebrafish. Acta Histochem. 2013.
13. Her GM, Pai WY, Lai CY, Hsieh YW, Pang HW. Ubiquitous transcription factor YY1 promotes zebrafish liver steatosis and lipotoxicity by inhibiting CHOP-10 expression. Biochim Biophys Acta. 2013;1831(6):1037-51.
14. Her GM, Hsu CC, Hong JR, Lai CY, Hsu MC, Pang HW, et al. Overexpression of gankyrin induces liver steatosis in zebrafish (Danio rerio). Biochim Biophys Acta. 2011;1811(9):536-48.
15. Shieh YS, Chang YS, Hong JR, Chen LJ, Jou LK, Hsu CC, et al. Increase of hepatic fat accumulation by liver specific expression of Hepatitis B virus X protein in zebrafish. Biochim Biophys Acta. 2010;1801(7):721-30.
16. Matsumoto T, Terai S, Oishi T, Kuwashiro S, Fujisawa K, Yamamoto N, et al. Medaka as a model for human nonalcoholic steatohepatitis. Dis Model Mech. 2010;3(7-8):431-40.
17. Oka T, Nishimura Y, Zang L, Hirano M, Shimada Y, Wang Z, et al. Diet-induced obesity in zebrafish shares common pathophysiological pathways with mammalian obesity. BMC Physiol. 2010;10:21.
18. Amali AA, Rekha RD, Lin CJ, Wang WL, Gong HY, Her GM, et al. Thioacetamide induced liver damage in zebrafish embryo as a disease model for steatohepatitis. J Biomed Sci. 2006;13(2):225-32.
19. Passeri MJ, Cinaroglu A, Gao C, Sadler KC. Hepatic steatosis in response to acute alcohol exposure in zebrafish requires sterol regulatory element binding protein activation. Hepatology (Baltimore, Md). 2009;49(2):443-52.
20. Sapp V, Gaffney L, EauClaire SF, Matthews RP. Fructose leads to hepatic steatosis in zebrafish that is reversed by mTOR inhibition. Hepatology (BaltimoreMd). 2014;60(5):1581-92.
21. Torres DM, Harrison SA. Is it time to write a prescription for coffee? Coffee and liver disease. Gastroenterology. 2013;144(4):670-2.
22. Dranoff JA, Feld JJ, Lavoie ÉG, Fausther M. How does coffee prevent liver fibrosis? biological plausibility for recent epidemiological observations. Hepatology (Baltimore, Md). 2014.
23. Klatsky AL, Armstrong MA. Alcohol, smoking, coffee, and cirrhosis. Am J Epidemiol. 1992;136(10):1248-57.
24. Ranheim T, Halvorsen B. Coffee consumption and human health-beneficial or detrimental?-Mechanisms for effects of coffee consumption on different risk factors for cardiovascular disease and type 2 diabetes mellitus. Mol Nutr Food Res. 2005;49(3):274-84.
25. Huxley R, Lee CM, Barzi F, Timmermeister L, Czernichow S, Perkovic V, et al. Coffee, decaffeinated coffee, and tea consumption in relation to incident type 2 diabetes mellitus: A systematic review with meta-analysis. Arch Intern Med. 2009;169(22):2053-63.
26. Jiang X, Zhang D, Jiang W. Coffee and caffeine intake and incidence of type 2 diabetes mellitus: A meta-analysis of prospective studies. Eur J Nutr. 2014;53(1):25-38.
27. Molloy JW, Calcagno CJ, Williams CD, Jones FJ, Torres DM, Harrison SA. Association of coffee and caffeine consumption with fatty liver disease, nonalcoholic steatohepatitis, and degree of hepatic fibrosis. Hepatology (Baltimore, Md). 2012;55(2):429.
28. Gutierrez-Grobe Y, Chavez-Tapia N, Sanchez-Valle V, Gavilanes-Espinar JG, Ponciano-Rodriguez G, Uribe M, et al. High coffee intake is associated with lower grade nonalcoholic fatty liver disease: The role of peripheral antioxidant activity. Ann Hepatol. 2012;11(3):350-5.
29. Birerdinc A, Stepanova M, Pawloski L, Younossi ZM. Caffeine is protective in patients with non-alcoholic fatty liver disease. Aliment Pharmacol Ther. 2012;35(1):76-82.
30. Leung WW, Ho SC, Chan HL, Wong V, Yeo W, Mok TS. Moderate coffee consumption reduces the risk of hepatocellular carcinoma in hepatitis B chronic carriers: A case-control study. J Epidemiol Community Health. 2011;65(6):556-8.
31. Johnson S, Koh WP, Wang R, Govindarajan S, Yu MC, Yuan JM. Coffee consumption and reduced risk of hepatocellular carcinoma: Findings from the Singapore Chinese Health Study. Cancer Causes Control. 2011;22(3):503-10.
32. Larsson SC, Wolk A. Coffee consumption and risk of liver cancer: A meta-analysis. Gastroenterology. 2007;132(5):1740-5.
33. Bravi F, Bosetti C, Tavani A, Bagnardi V, Gallus S, Negri E, et al. Coffee drinking and hepatocellular carcinoma risk: A meta-analysis. Hepatology (Baltimore, Md). 2007;46(2):430-5.
34. Modi AA, Feld JJ, Park Y, Kleiner DE, Everhart JE, Liang TJ, et al. Increased caffeine consumption is associated with reduced hepatic fibrosis. Hepatology (Baltimore, Md). 2010;51(1):201-9.
35. Ruhl CE, Everhart JE. Coffee and caffeine consumption reduce the risk of elevated serum alanine aminotransferase activity in the United States. Gastroenterology. 2005;128(1):24-32.
36. Kalthoff S, Ehmer U, Freiberg N, Manns MP, Strassburg CP. Coffee induces expression of glucuronosyltransferases by the aryl hydrocarbon receptor and Nrf2 in liver and stomach. Gastroenterology. 2010;139(5):1699-710. 1710 e1691-1692.
37. Arauz J, Moreno MG, Cortes-Reynosa P, Salazar EP, Muriel P. Coffee attenuates fibrosis by decreasing the expression of TGF-beta and CTGF in a murine model of liver damage. J Appl Toxicol. 2013;33(9):970-9.
38. Sinha RA, Farah BL, Singh BK, Siddique MM, Li Y, Wu Y, et al. Caffeine stimulates hepatic lipid metabolism by the autophagy-lysosomal pathway in mice. Hepatology (Baltimore, Md). 2013.
39. Quan HY, Kim do Y, Chung SH. Caffeine attenuates lipid accumulation via activation of AMP-activated protein kinase signaling pathway in HepG2 cells. BMB Rep. 2013;46(4):207-12.
40. Liu W, Chen JR, Hsu CH, Li YH, Chen YM, Lin CY, et al. A zebrafish model of intrahepatic cholangiocarcinoma by dual expression of hepatitis B virus X and hepatitis C virus core protein in liver. Hepatology (Baltimore, Md). 2012;56(6):2268-76.
41. Schlegel A. Studying non-alcoholic fatty liver disease with zebrafish: A confluence of optics, genetics, and physiology. Cell Mol Life Sci. 2012;69(23):3953-61.
42. Hiramitsu M, Shimada Y, Kuroyanagi J, Inoue T, Katagiri T, Zang L, et al. Eriocitrin ameliorates diet-induced hepatic steatosis with activation of mitochondrial biogenesis. Sci Rep. 2014;4.
43. Tainaka T, Shimada Y, Kuroyanagi J, Zang L, Oka T, Nishimura Y, et al. Transcriptome analysis of anti-fatty liver action by Campari tomato using a zebrafish diet-induced obesity model. Nutrition & metabolism. 2011;8:88.
44. Baek JS, Fang L, Li AC, Miller YI. Ezetimibe and simvastatin reduce cholesterol levels in zebrafish larvae fed a high-cholesterol diet. Cholesterol. 2012;2012:564705.
45. Greenberg JA, Boozer CN, Geliebter A. Coffee, diabetes, and weight control. Am J Clin Nutr. 2006;84(4):682-93.
46. Zheng G, Sayama K, Okubo T, Juneja LR, Oguni I. Anti-obesity effects of three major components of green tea, catechins, caffeine and theanine, in mice. In Vivo. 2004;18(1):55-62.
47. Yoshioka K, Yoshida T, Kamanaru K, Hiraoka N, Kondo M. Caffeine activates brown adipose tissue thermogenesis and metabolic rate in mice. J Nutr Sci Vitaminol. 1990;36(2):173-8.
48. Su SH, Shyu HW, Yeh YT, Chen KM, Yeh H, Su SJ. Caffeine inhibits adipogenic differentiation of primary adipose-derived stem cells and bone marrow stromal cells. Toxicol In Vitro. 2013;27(6):1830-7.
49. Ruhl CE, Everhart JE. Coffee and tea consumption are associated with a lower incidence of chronic liver disease in the United States. Gastroenterology. 2005;129(6):1928-36.
50. Saiki S, Sasazawa Y, Imamichi Y, Kawajiri S, Fujimaki T, Tanida I, et al. Caffeine induces apoptosis by enhancement of autophagy via PI3K/Akt/mTOR/p70S6K inhibition. Autophagy. 2011;7(2):176-87.
51. Bode AM, Dong Z. The enigmatic effects of caffeine in cell cycle and cancer. Cancer Lett. 2007;247(1):26-39.
52. Jang MH, Shin MC, Kang IS, Baik HH, Cho YH, Chu JP, et al. Caffeine induces apoptosis in human neuroblastoma cell line SK-N-MC. J Korean Med Sci. 2002;17(5):674-8.
53. Miquilena-Colina ME, Lima-Cabello E, Sanchez-Campos S, Garcia-Mediavilla MV, Fernandez-Bermejo M, Lozano-Rodriguez T, et al. Hepatic fatty acid translocase CD36 upregulation is associated with insulin resistance, hyperinsulinaemia and increased steatosis in non-alcoholic steatohepatitis and chronic hepatitis C. Gut. 2011;60(10):1394-402.
54. Puri P, Mirshahi F, Cheung O, Natarajan R, Maher JW, Kellum JM, et al. Activation and dysregulation of the unfolded protein response in nonalcoholic fatty liver disease. Gastroenterology. 2008;134(2):568-76.
55. Hotamisligil GS. Endoplasmic Reticulum Stress and the Inflammatory Basis of Metabolic Disease. Cell. 2010;140(6):900-17.
56. Nakagawa H, Umemura A, Taniguchi K, Font-Burgada J, Dhar D, Ogata H, et al. Stress Cooperates with Hypernutrition to Trigger TNF-Dependent Spontaneous HCC Development. Cancer Cell. 2014;26(3):331-43.
57. Hosoi T, Toyoda K, Nakatsu K, Ozawa K. Caffeine attenuated ER stress-induced leptin resistance in neurons. Neurosci Lett. 2014;569:23-6.
58. Katayama M, Donai K, Sakakibara H, Ohtomo Y, Miyagawa M, Kuroda K, et al. Coffee consumption delays the hepatitis and suppresses the inflammation related gene expression in the Long-Evans Cinnamon rat. Clinical nutrition (Edinburgh, Scotland). 2014;33(2):302-10.